Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 27.07.2026 1 AJR Am J Roentgenol 1 Br J Cancer 1 Br J Radiol 1 Cancer Lett 1 Clin Cancer Res 5 Eur Urol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 2 Int J Urol 1 J Nucl Med 1 Oncogene 2 PLoS One 1 Proc Natl Acad Sci U S A 4 Prostate

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. SHETTY AS
   The Complementary Value of Prostate Bed MRI After a Negative PSMA PET/CT Examination in Prostate Cancer Biochemical Recurrence.
   AJR Am J Roentgenol. 2026 Jul 22. doi: 10.2214/AJR.26.35584.
   PubMed        
   
   

   
   Br J Cancer

2. TIEFENBACHER A, Gudenus M, Valcanover D, Neudert B, et al
   Adipose triglyceride lipase driven lipolysis as a targetable metabolic vulnerability in prostate cancer with intrinsic metabolic inflexibility.
   Br J Cancer. 2026 Jul 23. doi: 10.1038/s41416-026-03545.
   PubMed         Abstract available
   
   

   
   Br J Radiol

3. VELLA A, Padmanaban S, Robinson M
   Development and implementation of Automated Clinical Treatment Planning (ACT) for routine prostate and breast treatments.
   Br J Radiol. 2026;99:1558-1568.
   PubMed         Abstract available
   
   

   
   Cancer Lett

4. WILLIAMS EC, Shibata M
   Prostate luminal cell plasticity and cancer.
   Cancer Lett. 2025;611:217430.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

5. TAGAWA ST, Thomas C, Arham AB, Holmes A, et al
   A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.
   Clin Cancer Res. 2026 Jul 22. doi: 10.1158/1078-0432.CCR-26-0689.
   PubMed         Abstract available
   
   

   
   Eur Urol

6. BLANCHARD P, Sighinolfi C, Terlizzi M, Rocco B, et al
   Five-Year Patient-Reported Outcomes After SBRT for Prostate Cancer: A Benchmark for Radiotherapy, but How Far Across Modalities?
   Eur Urol. 2026 Jul 24:S0302-2838(26)02300-6. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   
7. MORTEZAVI A, van der Hulle T, van den Bergh R
   What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.
   Eur Urol. 2026 Jul 23:S0302-2838(26)02258-X. doi: 10.1016/j.eururo.2026.
   PubMed         Abstract available
   
   
8. ULERI A, Baboudjian M, Lughezzani G, Ploussard G, et al
   Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Effect of [(68)Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings on Multiparametric MRI (PRIMARY2): A Multicenter,
   Eur Urol. 2026 Jul 23:S0302-2838(26)02269-4. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   
9. KIM JS, Chang AR, Kim JH
   Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029.
   Eur Urol. 2026 Jul 23:S0302-2838(26)02276-1. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   
10. NGUYEN DD, Najafabadi BT, Lin L, Kwong JCC, et al
    Reply to J.H. Kim and Y.S. Shin's Letter to the Editor re: Re: Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled T
    Eur Urol. 2026 Jul 21:S0302-2838(26)02272-4. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    

    
    Int J Cancer

11. BOTTING-PROVOST S, Ng K, Laurie C, Noorani R, et al
    The Association Between Human Papillomavirus and Prostate Cancer: A Systematic Review and Meta-Analysis.
    Int J Cancer. 2026 Jul 21. doi: 10.1002/ijc.70663.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

12. TAKAYESU JSK, Xie T, Aldous J, Nasser B, et al
    ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2026 Jul 19:S0360-3016(26)04013.
    PubMed         Abstract available
    
    

    
    Int J Urol

13. MITA Y, Teishima J, Ueki H, Wakita N, et al
    Effects of Modifying Hinotori Surgical Robot System on the Learning Curve of Robot-Assisted Radical Prostatectomy.
    Int J Urol. 2026;33:e70577.
    PubMed         Abstract available
    
    
14. HATA K, Goto Y, Hashimoto M, Okamoto M, et al
    Bleeding Events Associated With Continuing Antithrombotic Therapy During Transrectal Ultrasound-Guided Prostate Biopsy: A Propensity Score-Matched Analysis.
    Int J Urol. 2026;33:e70580.
    PubMed         Abstract available
    
    

    
    J Nucl Med

15. KARIMZADEH A, Futterer C, Hansen K, Coban O, et al
    Outcome Prediction After [(177)Lu]Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: External Validation of a [(68)Ga]Ga-PSMA-11 PET-Based Model with [(18)F]F-Flotufolastat.
    J Nucl Med. 2026 Jul 23:jnumed.125.270944. doi: 10.2967/jnumed.125.270944.
    PubMed         Abstract available
    
    

    
    Oncogene

16. WANG KJ, Wang KY, Chen SX, Ma YT, et al
    RON receptor tyrosine kinase regulates abiraterone resistance in prostate cancer via the methylation-dependent and independent dual functions of DNMT1.
    Oncogene. 2026 Jul 24. doi: 10.1038/s41388-026-03906.
    PubMed         Abstract available
    
    

    
    PLoS One

17. NAKAJIMA N, Kazama T, Takahara T, Oda K, et al
    Efficacy and limitations of diffusion-weighted imaging with background suppression-based whole-body magnetic resonance imaging in high-risk prostate cancer staging: A retrospective study.
    PLoS One. 2026;21:e0354601.
    PubMed         Abstract available
    
    
18. YOON E, Cho JD, Choi CH, Kim JH, et al
    In vivo rectal dosimeter with MRI marker.
    PLoS One. 2026;21:e0354149.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. GUAN H, Mao L, Fang F, Wu T, et al
    ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-gamma efficacy in prostate cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2603231123.
    PubMed         Abstract available
    
    

    
    Prostate

20. GONZALEZ-MARTINEZ CA, Alcacio-Mendoza JA, Hernandez-Ramirez R, Lagos-Beitz HE, et al
    Intense Focal Peripheral Uptake Pattern on 18F-PET/PSMA as a Predictor of Histological Upgrading in Prostate Cancer.
    Prostate. 2026 Jul 23. doi: 10.1002/pros.70220.
    PubMed         Abstract available
    
    
21. SUZUKI K, Hirata J, Ueki H, Wakita N, et al
    Prognostic Significance of the Modified Glasgow Prognostic Score and Systemic Immune-Inflammation Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel.
    Prostate. 2026 Jul 19. doi: 10.1002/pros.70227.
    PubMed         Abstract available
    
    
22. TANAKA Y, Shimizu F, Abudurezake A, Diabangouaya M, et al
    Enhancing Continence Recovery After Robot-Assisted Radical Prostatectomy: A Novel Combined Approach Using Testosterone Therapy and Magnetic Stimulation.
    Prostate. 2026 Jun 9. doi: 10.1002/pros.70205.
    PubMed         Abstract available
    
    
23. FURUMIDO J, Nonoyama S, Hoshi C (Hosokawa), Aizawa S, et al
    Real-World Clinical Evaluation of S2,3PSA Test in a Prostate Biopsy Cohort With PSA Level of 4-10 ng/mL.
    Prostate. 2026;86:1258-1262.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum